PUBLISHED

N.C.G.S. § 90-85.63

Report and data collection by the Secretary; public portal.

Effective date: 2026-08-08
Last verified: 2026-08-09
Source: official source
Revision history: view all versions

(a) Plan for Implementation. - The Secretary shall develop a plan to collect data from manufacturers pursuant to G.S. 90-85.61 to provide transparency and accountability for prescription drug pricing. The Secretary shall consult with other state and national agencies and nonprofit organizations to determine how to implement this data collection directive but shall not disclose any confidential, proprietary, or trade secret information. (b) Public Portal. - The Secretary shall create an online portal to provide the public with access to the notifications, reports, and other disclosures required by this Article. (c) Annual Report. - Beginning January 1, 2027, and annually thereafter, the Secretary shall report to the Joint Legislative Oversight Committee on Health and Human Services the following information with respect to prescription drugs sold in this State: (1) The 25 drugs prescribed most frequently in the State. (2) The 25 most costly drugs based on the total amount spent on those drugs by consumers in this State. (3) The 25 drugs with the greatest percentage cost increases during the prior calendar year. (4) The 10 manufacturers with the greatest average percentage cost increase for the prior calendar year for all drugs sold by that manufacturer in the State. (2025-69, s. 8(a).)